Jim Cramer’s 5 Stock Calls: Sandisk, Marvell, and AMD

In this article, we will look at Jim Cramer’s 5 Stock Calls: Sandisk, Marvell, and AMD. Please visit Jim Cramer’s 12 Stock Calls: GE Vernova, Arm, and Vertiv, if you’d like to see the extended list and methodology behind it.

5. Merck & Co., Inc. (NYSE:MRK)

Merck & Co., Inc. (NYSE:MRK) was among Jim Cramer’s stock calls as he suggested that many red-hot stocks can keep making investors money. A caller asked whether they should stick with the stock or switch to another one. Cramer replied:

Okay, I’ve gotta tell you, this rotation out of healthcare is one of the most breathtaking rotations. We could be talking about a half dozen drug stocks, and they would all be the same. I think that Merck is at 13 times earnings. I think Merck is terrific. I don’t think that matters at all. I think the stock could drop another five, so you want to buy some and then leave, I like to say leave room. Hey, maybe divide by 10. It’s an $11 stock. Maybe it goes to 10 and a half.

Merck & Co., Inc. (NYSE:MRK) is a healthcare company that provides a wide range of human and veterinary pharmaceuticals, vaccines, and health solutions. TCW Relative Value Large Cap Fund stated the following regarding Merck & Co., Inc. (NYSE:MRK) in its fourth quarter 2025 investor letter:

The best performing stocks in the quarter were Alphabet†, Intel (INTC; 2.69%**), and Merck & Co., Inc. (NYSE:MRK) (MRK; 2.70%**). Merck & Co. shares jumped after the company reported better than expected third quarter revenues. Management attributed the beat to cost cutting initiatives and strong sales of its pneumonia vaccine.